Back to Journals » Infection and Drug Resistance » Volume 2

Anidulafungin and its role in candida infections

Authors Diane M Cappelletty, Rose Jung

Published 30 June 2009 Volume 2009:2 Pages 51—60

DOI https://doi.org/10.2147/IDR.S4796

Review by Single-blind

Peer reviewer comments 3

Diane M Cappelletty, Rose Jung

The University of Toledo, College of Pharmacy, Toledo, OH, USA

Abstract: Candida infections continue to play a significant role not only in critically ill and immunocompromised patients but also in non-compromised patients. The incidence of systemic fungal infections in the United States has been on the rise for the past 30 years. Anidulafungin and all echinocandins inhibit glucan synthase thus inhibiting the formation of 1,3-β-D-glucan which is an essential component of the fungal cell wall. The decrease in 1,3-β-D-glucan results in the osmotic lysis of the cell, resulting in fungicidal activity against candida. Anidulafungin is active against most species of candida and resistance to it is very rare. Two potential mechanisms conferring reduced susceptibility to the echinocandins are efflux and target alteration. The efflux pump associated with fluconazole resistance in Candida albicans can confer higher minimum inhibitory concentrations to caspofungin. The second mechanism of resistance is via mutations in the genes which code for 1,3 β-D-glucan synthase, specifically FKS1. Because of its spectrum of activity, fungicidal nature, and tolerability it is an attractive first-line therapeutic choice for treating candidemia in both non-neutropenic and neutropenic patients. Because it is available only parenterally its role in treating mucocutaneous candidiasis is primarily in patients unable to take oral therapy.

Keywords: anidulafungin, candida, echinocandin

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Growth curves and their implications in hand-fed Monk parrots (Myiopsitta monachus)

Petzinger C, Heatley JJ, Bauer JE

Veterinary Medicine: Research and Reports 2015, 6:321-327

Published Date: 15 October 2015

Modeling human influenza infection in the laboratory

Radigan KA, Misharin AV, Chi M, Scott Budinger GR

Infection and Drug Resistance 2015, 8:311-320

Published Date: 31 August 2015

Alterations with age in peripheral blood lymphocyte subpopulations and cytokine synthesis in beagles

Fujiwara M, Yonezawa T, Arai T, Yamamoto I, Ohtsuka H

Veterinary Medicine: Research and Reports 2012, 3:79-84

Published Date: 27 August 2012

A review of the pathology and treatment of canine respiratory infections

Vieson MD, Piñeyro P, LeRoith T

Veterinary Medicine: Research and Reports 2012, 3:25-39

Published Date: 27 June 2012

Topical diclofenac in the treatment of osteoarthritis of the knee

Niklas Schuelert, Fiona A Russell, Jason J McDougall

Orthopedic Research and Reviews 2011, 3:1-8

Published Date: 6 February 2011